COVID-19 Diagnostics Market climb to surpass the valuation o

The COVID-19 diagnostics market is positioned for exceptional growth, projecting a substantial climb to surpass the valuation of US$ 204.51 billion by 2032, driven by an impressive compound annual growth rate (CAGR) of 7.7%. This anticipated surge reflects the crucial role of diagnostic tools in managing the ongoing...

Related Keywords

Delaware , United States , New York , America , Canakinumab Ilaris , Sdn Bhd , Route Of Administration , Gilead Sciences , Laboratory Corporation Of America Holdings , Perkin Elmer Inc , Consumer Technology , Luminex Corporation , Market Insights Inc , Thermo Fisher Scientific Inc , Mylab Discovery Solutions Pvt Ltd , Greater New York Chamber , Hologic Inc , Quidel Corporation , Novacyt Group , Novartis , Cepheid , Complimentary Report , Drug Class , Market Players , Sorrento Therapeutics , Veredus Laboratories , Thermo Fisher Scientific , Perkin Elmer , Neuberg Diagnostics , Laboratory Corporation , America Holdings , Altona Diagnostics Gmbh , Future Market Insights , Market Insights , Stevie Award , Sales Enquiries ,